Intra-Cellular Therapies Stock (NASDAQ: ITCI) stock price, news, charts, stock research, profile.
Open | $74.54 |
Close | $74.48 |
Volume / Avg. | 268.23K / 1.06M |
Day Range | $74.00 - $74.81 |
52 Wk Range | 45.50 - 84.89 |
Market Cap | $7.87B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 2.71% |
Days to Cover | 3.39 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Intra-Cellular Therapies (NASDAQ:ITCI) through any online brokerage.
Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).
Intra-Cellular Therapies has a consensus price target of $89.25.
The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $74.48 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Intra-Cellular Therapies.
Intra-Cellular Therapies’s Q3 earnings are confirmed for Thursday, October 31, 2024.
There is no upcoming split for Intra-Cellular Therapies.
Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.